PureTech Health (NASDAQ:PRTC) Trading Up 3.5% – Here’s Why

PureTech Health plc (NASDAQ:PRTC) shares rose 3.5% on Monday . The company traded as high as $16.82 and last traded at $17.30. Approximately 650 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 3,900 shares. The stock had previously closed at $16.71.

PureTech Health Stock Up 3.5 %

The stock’s 50 day moving average price is $18.22 and its 200-day moving average price is $19.69.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in PureTech Health stock. Millennium Management LLC purchased a new position in PureTech Health plc (NASDAQ:PRTC) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 45,264 shares of the company’s stock, valued at approximately $823,000. Millennium Management LLC owned about 0.19% of PureTech Health as of its most recent SEC filing. Institutional investors and hedge funds own 0.04% of the company’s stock.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.